One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
New and Emerging Rheumatic Diseases
ERIN JANSSEN
doi : 10.1016/S0889-857X(23)00094-7
Volume 49, Issue 4, November 2023, Page i
Emerging Concepts in Immune Dysregulation
Michael H. Weisman, MD
doi : 10.1016/j.rdc.2023.08.013
Volume 49, Issue 4, November 2023, Pages xiii-xiv
Emerging Concepts in Immune Dysregulation
Erin Janssen, MD, PhD
doi : 10.1016/j.rdc.2023.08.012
Volume 49, Issue 4, November 2023, Pages xv-xvi
Approach to Diagnosing Inborn Errors of Immunity
Xiao Peng, MD, PhD a , Saara Kaviany, DO b, *
doi : 10.1016/j.rdc.2023.06.001
Volume 49, Issue 4, November 2023, Pages 731-739
Type I Interferonopathies: A Clinical Review
Christine S. Wang,
doi : 10.1016/j.rdc.2023.06.002
Volume 49, Issue 4, November 2023, Pages 741-756
Suppressor of Cytokine Signaling 1 Haploinsufficiency: A New Driver of Autoimmunity and Immunodysregulation
Meng Liu, MD a,b , Evan Hsu a , Yan Du, MD, PhD a,c , Pui Y. Lee, MD, PhD
doi : 10.1016/j.rdc.2023.06.003
Volume 49, Issue 4, November 2023, Pages 757-772
Deficiency of Adenosine Deaminase 2: Clinical Manifestations, Diagnosis, and Treatment
Andrew Grim, MD a , Keila R. Veiga, MD b,1 , Nadine Saad, MD a, *
doi : 10.1016/j.rdc.2023.06.004
Volume 49, Issue 4, November 2023, Pages 773-787
COPA Syndrome from Diagnosis to Treatment: A Clinician’s Guide
Noa Simchoni, MD, PhD a , Tiphanie P. Vogel, MD, PhD b , Anthony K. Shum, MD
doi : 10.1016/j.rdc.2023.06.005
Volume 49, Issue 4, November 2023, Pages 789-804
NF-κB and Related Autoimmune and Autoinflammatory Diseases
George E. Freigeh, MD, MA a, *, Thomas F. Michniacki, MD
doi : 10.1016/j.rdc.2023.06.008
Volume 49, Issue 4, November 2023, Pages 805-823
Expanding IPEX: Inborn Errors of Regulatory T Cells
Holly Wobma, MD, PhD a , Erin Janssen, MD, PhD
doi : 10.1016/j.rdc.2023.06.009
Volume 49, Issue 4, November 2023, Pages 825-840
Understanding the Spectrum of Immune Dysregulation Manifestations in Autoimmune Lymphoproliferative Syndrome and Autoimmune Lymphoproliferative Syndrome-like Disorders
Christopher Failing, MD a,b, *, Jennifer R. Blase, MD, PhD c , Kelly Walkovich, MD c
doi : 10.1016/j.rdc.2023.07.001
Volume 49, Issue 4, November 2023, Pages 841-860
Genetic Defects in Early-Onset Inflammatory Bowel Disease
Atiye Olcay Bilgic Dagci, MD a, *, Kelly Colleen Cushing, MD
doi : 10.1016/j.rdc.2023.06.006
Volume 49, Issue 4, November 2023, Pages 861-874
Mechanisms and Emerging Therapies for Treatment of Seizures in Pediatric Autoimmune Encephalitis and Autoinflammatory/Autoimmune-Associated Epilepsy
Milena M. Andzelm, MD, PhD a , Coral M. Stredny, MD a,
doi : 10.1016/j.rdc.2023.06.010
Volume 49, Issue 4, November 2023, Pages 875-893
Molecular Pathways in the Pathogenesis of Systemic Juvenile Idiopathic Arthritis
Grant S. Schulert, MD, PhD a, *, Christoph Kessel, PhD
doi : 10.1016/j.rdc.2023.06.007
Volume 49, Issue 4, November 2023, Pages 895-911
Targeted Treatment of Diseases of Immune Dysregulation
Smriti Mohan,
doi : 10.1016/j.rdc.2023.07.002
Volume 49, Issue 4, November 2023, Pages 913-929
